283 related articles for article (PubMed ID: 19842230)
1. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H
Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H; Blewett CJ
Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH
World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
[TBL] [Abstract][Full Text] [Related]
6. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials.
Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K
Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650
[TBL] [Abstract][Full Text] [Related]
8. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma.
Huang Y; Wang H; Luo G; Zhang Y; Wang L; Li K
Int J Surg; 2017 Feb; 38():41-47. PubMed ID: 28027995
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.
Wang DB; Zhang X; Han HL; Xu YJ; Sun DQ; Shi ZL
Dig Dis Sci; 2012 Dec; 57(12):3226-33. PubMed ID: 22695886
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma.
Wang F; Wang YM; He W; Li XK; Peng FH; Yang XL; Fan QX
Chin Med J (Engl); 2013 Aug; 126(16):3138-45. PubMed ID: 23981626
[TBL] [Abstract][Full Text] [Related]
12. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
Gebski V; Burmeister B; Smithers BM; Foo K; Zalcberg J; Simes J;
Lancet Oncol; 2007 Mar; 8(3):226-34. PubMed ID: 17329193
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.
Deng J; Wang C; Xiang M; Liu F; Liu Y; Zhao K
Diagn Pathol; 2014 Jul; 9():151. PubMed ID: 25030066
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
Malthaner RA; Wong RK; Rumble RB; Zuraw L;
BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.
Lew JI; Gooding WE; Ribeiro U; Safatle-Ribeiro AV; Posner MC
Arch Surg; 2001 Jul; 136(7):737-42; discussion 743. PubMed ID: 11448381
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemoradiotherapy combined with operation vs. operation alone for resectable esophageal cancer: Meta-analysis on randomized controlled trials].
Duan X; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):809-815. PubMed ID: 28722096
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials.
Kumar T; Pai E; Singh R; Francis NJ; Pandey M
World J Surg Oncol; 2020 Mar; 18(1):59. PubMed ID: 32199464
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
Fiorica F; Di Bona D; Schepis F; Licata A; Shahied L; Venturi A; Falchi AM; Craxì A; Cammà C
Gut; 2004 Jul; 53(7):925-30. PubMed ID: 15194636
[TBL] [Abstract][Full Text] [Related]
19. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Sjoquist KM; Burmeister BH; Smithers BM; Zalcberg JR; Simes RJ; Barbour A; Gebski V;
Lancet Oncol; 2011 Jul; 12(7):681-92. PubMed ID: 21684205
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]